N. I. Giritlioglu Et Al. , "Cost-effective isolation of Viburnum opulus-derived nanovesicles and evaluation of their cytotoxic, anticancer, and antioxidant properties on human glioblastoma cell line U87MG," Medical Oncology , vol.42, no.4, 2025
Giritlioglu, N. I. Et Al. 2025. Cost-effective isolation of Viburnum opulus-derived nanovesicles and evaluation of their cytotoxic, anticancer, and antioxidant properties on human glioblastoma cell line U87MG. Medical Oncology , vol.42, no.4 .
Giritlioglu, N. I., Poyraz, F. Ş., Mansuroglu, B., & Erisen, S., (2025). Cost-effective isolation of Viburnum opulus-derived nanovesicles and evaluation of their cytotoxic, anticancer, and antioxidant properties on human glioblastoma cell line U87MG. Medical Oncology , vol.42, no.4.
Giritlioglu, Nazli Et Al. "Cost-effective isolation of Viburnum opulus-derived nanovesicles and evaluation of their cytotoxic, anticancer, and antioxidant properties on human glioblastoma cell line U87MG," Medical Oncology , vol.42, no.4, 2025
Giritlioglu, Nazli I. Et Al. "Cost-effective isolation of Viburnum opulus-derived nanovesicles and evaluation of their cytotoxic, anticancer, and antioxidant properties on human glioblastoma cell line U87MG." Medical Oncology , vol.42, no.4, 2025
Giritlioglu, N. I. Et Al. (2025) . "Cost-effective isolation of Viburnum opulus-derived nanovesicles and evaluation of their cytotoxic, anticancer, and antioxidant properties on human glioblastoma cell line U87MG." Medical Oncology , vol.42, no.4.
@article{article, author={Nazli Irmak Giritlioglu Et Al. }, title={Cost-effective isolation of Viburnum opulus-derived nanovesicles and evaluation of their cytotoxic, anticancer, and antioxidant properties on human glioblastoma cell line U87MG}, journal={Medical Oncology}, year=2025}